Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body’s anticancer immune response.
Columbia University researchers have identified a way to help predict when people at high risk of developing Alzheimer’s are likely to develop their first symptoms, a finding that could help physicians decide when to prescribe preventive treatments currently in development.
Drawing on research pioneered at Tufts, Anodyne Nanotech is creating patches that could change the future of medicine
A family of nanoparticles—tiny, biodegradable molecules commonly used to deliver drugs to patients—shows promise in treating Alzheimer’s disease without additional medication, according to new research from a University of Alberta neuroscientist.
CAR T cell therapy, which involves genetically modifying a patient’s own immune cells to fight cancer, is a technique that has shown great promise, especially against blood cancers. But currently, only about 4% of patients with advanced or metastatic cancer in the United States are candidates for CAR T therapy, and closer to 3% will actually benefit, according to one recent analysis.
Functional magnetic resonance imaging, or fMRI, gives researchers a powerful way to study brain activity. But the scans can be incredibly noisy for patients and research subjects, with peak sound levels reaching 120 to 138 decibels—about as loud as a jackhammer.
A new wireless device—lighter than a U.S. dime and shaped like a tiny chef’s hat—can track the brain waves of animals as they move in natural habitats, opening doors to understanding complex behaviors that are impossible to study in the lab.
A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children’s Hospital and Seattle Children’s describes a complete regression of hepatoblastoma, the most common pediatric liver cancer, in a 3-year-old treated with a novel immunotherapy.
WashU Medicine researchers led by Jacco Boon, a professor in the John T. Milliken Department of Medicine, report that an experimental bird flu vaccine provides strong immune protection in mice, including in animals previously vaccinated against seasonal flu. Because pre-existing immunity from prior seasonal influenza infection or vaccination could diminish the efficacy of H5N1 vaccines, showing that the new vaccine succeeds alongside existing immunity is a crucial milestone.
An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and Professor Dr. Roman Thomas at the University of Cologne has identified a critical dependency in small cell lung cancer (SCLC) that can be exploited therapeutically.